Clik here to view.
PharmTech Biomanufacturing Partnership Conference: The Rising Bar in Outsourcing
What will be the future of pharmaceutical outsourcing? What factors will influence the relationships between sponsor companies and contract service providers and what practical solutions are both...
View ArticlePharmaceutical-Based Cargo Security and Theft Prevention
Cargo theft, for many years, was a problem that largely plagued the electronics industry, but criminals have recently shifted more attention to the far more lucrative pharmaceutical trade. In March...
View ArticleUSP Updates Heparin Sodium Monograph
In 2008, adverse affects and deaths linked to Baxter’s blood thinner drug heparin revealed contamination in the heparin supply chain originating from an API manufacturer in China. FDA identified...
View ArticleOdorous Taints Linked to Treated Wood Pallets
It is amazing what the human nose knows. Well, those who originally detected a musty, moldy odor in pharmaceutical and healthcare products didn’t know where it came from. But the odorous taints that...
View ArticleCMC Troubles? Send Us Your Questions
Pharmaceutical Technology and Patheon are partnering to provide you—our readers—with CMC advice from some of the leading formulation scientists and pharmaceutical manufacturing experts in the world. To...
View ArticleClik here to view.
When Disaster Strikes at Home
The editorial offices of PharmTech are based in New Jersey, so when Hurricane Sandy hit last month, we were all affected. Flooding and high winds destroyed many coastline homes along with well-known...
View ArticleSpot Shortages and New Approvals for US Influenza Vaccine
Recently, after reading about the severity of this year’s flu season, I finally went and got my vaccine, which my doctor had been out of when I tried in October. I received one of the last doses the...
View ArticlePhRMA Dismayed by Special 301 Report
Pharmaceutical Research and Manufacturers of America (PhRMA) International Vice-President Jay Taylor has expressed the organization’s concerns over the Office of the United States Trade...
View ArticleClik here to view.
Quality Focus: Ensuring Raw Material Transparency
Quality is of utmost importance in drug development and manufacturing. The increased globalization of the pharmaceutical and biopharmaceutical industries, resulting in more complex and elongated...
View ArticleClik here to view.
Risk-Mitigation Strategies in Drug Manufacturing for Emerging Markets
Risk and reward. It is a balance that has to be achieved in any business endeavor and is of utmost importance for pharmaceutical and biopharmaceutical companies managing their growth and manufacturing...
View ArticlePrepare for Serialization Now
Upcoming requirements in the US and around the world for serialization and track and trace of pharmaceuticals were a focus of the Pharmapack conference held in Philadelphia, PA earlier this week....
View ArticleCourt Ruling Threatens Drug Shortage Remedy
The Food and Drug Administration may no longer be able to alleviate shortages in vital drugs by permitting the import of unapproved medicines following a decision by the US Court of Appeals for the...
View ArticleHealth Reform May Boost Illicit Drug Sales
Health plans that limit drug converge may encourage consumers to obtain medicines illegally, according to pharmacy experts. Marv Shepherd, director of the Center for Pharmacoeconomic Studies at the...
View ArticleDrug Shortages Continue to Plague Healthcare System
Despite notable successes in preventing and mitigating short supplies of important medicines, the drug shortage crisis still disrupts medical treatment and gives drug manufacturers a bad name. FDA is...
View ArticleSupplier Audit Program Marks Progress
The Rx360 pharmaceutical supply chain consortium celebrated its first five years with an anniversary conference the week of June 5, 2014 in Washington, D.C. The conference featured key FDA officials...
View Article
